<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Markwart, Robby</style></author><author><style face="normal" font="default" size="100%">Lehmann, Lena-Sophie</style></author><author><style face="normal" font="default" size="100%">Krause, Markus</style></author><author><style face="normal" font="default" size="100%">Jung, Paul</style></author><author><style face="normal" font="default" size="100%">Rost, Liliana</style></author><author><style face="normal" font="default" size="100%">Doepfmer, Susanne</style></author><author><style face="normal" font="default" size="100%">Kuempel, Lisa</style></author><author><style face="normal" font="default" size="100%">Kuschick, Doreen</style></author><author><style face="normal" font="default" size="100%">Toutaoui, Kahina J</style></author><author><style face="normal" font="default" size="100%">Heintze, Christoph</style></author><author><style face="normal" font="default" size="100%">Bleidorn, Jutta</style></author><author><style face="normal" font="default" size="100%">Wolf, Florian</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Utilisation and consequences of CRP point-of-care-testing in primary care practices: a real-world multicentre observational study with 1740 patient cases in Germany</style></title><secondary-title><style face="normal" font="default" size="100%">BJGP Open</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2025-04-01 00:00:00</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">BJGPO.2024.0120</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.3399/BJGPO.2024.0120</style></doi><volume><style face="normal" font="default" size="100%">9</style></volume><issue><style face="normal" font="default" size="100%">1</style></issue><abstract><style  face="normal" font="default" size="100%">Background C-reactive protein point-of-care tests (CRP-POCTs) can support GPs' clinical decision making but they are not widely used in German general practices.Aim To investigate the utilisation of semi-quantitative CRP-POCTs in routine primary care.Design &amp; setting Prospective observational study in 49 general practices in Germany (from November 2022–April 2023).Method GPs were provided with CRP-POCTs and collected data for each CRP-POCT use, with standardised data-collection sheets.Results Data from 1740 CRP-POCT uses were recorded. GPs employed CRP-POCTs mainly for patients with respiratory tract infections (RTIs; 71.2% of all cases) and to a lesser extent for gastrointestinal infections (GIs; 10.4%). In RTIs, CRP-POCTs were frequently used to distinguish between bacterial and viral aetiology (60.8%) and to guide decisions on antibiotic prescribing (62.8%). In GIs, CRP-POCTs were mainly used to rule out severe disease progressions (53.2%) and for decisions on further diagnostic procedures (45.6%). In RTIs, CRP-POCTs influenced antibiotic prescribing in 77.5% of the cases (32.3% in favour versus 45.2% waiver). In GIs, CRP levels mainly affected decisions on further diagnostic procedures. GPs reported that CRP-POCTs were helpful in 88.6% of all cases.Conclusion When available, German GPs predominantly use semi-quantitative CRP-POCTs to guide decisions on antibiotic prescribing in patients with RTIs. CRP-POCT use improves clinical decision making and increases the GP’s clinical confidence.</style></abstract></record></records></xml>